NCT05827536View on ClinicalTrials.gov

Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Phenylketonurias
Interventions
DIETARY_SUPPLEMENT

PKU GOLIKE

PKU GOLIKE is a food for special medicinal purposes (FSMP) for the dietary management of PKU.

DIETARY_SUPPLEMENT

Standard of Care

Protein substitute

Trial Locations (1)

20142

RECRUITING

ASST Santi Paolo e Carlo, Presidio Ospedale San Paolo, Via Antonio di Rudinì 8, Milan

Sponsors
All Listed Sponsors
lead

APR Applied Pharma Research s.a.

OTHER